annual SGA:
$237.31M+$128.61M(+118.32%)Summary
- As of today (May 24, 2025), TARS annual SGA is $237.31 million, with the most recent change of +$128.61 million (+118.32%) on December 31, 2024.
- During the last 3 years, TARS annual SGA has risen by +$211.91 million (+834.40%).
- TARS annual SGA is now at all-time high.
Performance
TARS SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$85.00M+$15.96M(+23.13%)Summary
- As of today (May 24, 2025), TARS quarterly SGA is $85.00 million, with the most recent change of +$15.96 million (+23.13%) on March 31, 2025.
- Over the past year, TARS quarterly SGA has increased by +$33.42 million (+64.79%).
- TARS quarterly SGA is now at all-time high.
Performance
TARS quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
-$1.40B-$104.94M(-8.13%)Summary
- As of today (May 24, 2025), TARS TTM SGA is -$1.40 billion, with the most recent change of -$104.94 million (-8.13%) on March 31, 2025.
- Over the past year, TARS TTM SGA has dropped by -$1.54 billion (-1061.77%).
- TARS TTM SGA is now -23040.77% below its all-time high of -$6.03 million.
Performance
TARS TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
TARS Selling, general & administrative expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +118.3% | +64.8% | -1061.8% |
| 3 y3 years | +834.4% | +969.7% | -5054.4% |
| 5 y5 years | +10000.0% | +10000.0% | -10000.0% |
TARS Selling, general & administrative expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +834.4% | at high | +969.7% | -764.5% | at low |
| 5 y | 5-year | at high | >+9999.0% | at high | >+9999.0% | -7982.9% | at low |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% | <-9999.0% | at low |
TARS Selling, general & administrative expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $85.00M(+23.1%) | $270.73M(+14.1%) |
| Dec 2024 | $237.31M(+118.3%) | $69.03M(+19.2%) | $237.31M(+12.3%) |
| Sep 2024 | - | $57.91M(-1.5%) | $211.28M(+15.0%) |
| Jun 2024 | - | $58.79M(+14.0%) | $183.70M(+26.5%) |
| Mar 2024 | - | $51.58M(+19.9%) | $145.18M(+33.6%) |
| Dec 2023 | $108.70M(+141.8%) | $43.01M(+41.8%) | $108.70M(+35.3%) |
| Sep 2023 | - | $30.32M(+49.6%) | $80.33M(+29.6%) |
| Jun 2023 | - | $20.27M(+34.3%) | $62.00M(+19.0%) |
| Mar 2023 | - | $15.10M(+3.2%) | $52.10M(+15.9%) |
| Dec 2022 | $44.95M | $14.63M(+22.0%) | $44.95M(+21.2%) |
| Sep 2022 | - | $11.99M(+15.6%) | $37.09M(+16.8%) |
| Jun 2022 | - | $10.38M(+30.6%) | $31.77M(+12.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $7.95M(+17.3%) | $28.18M(+11.0%) |
| Dec 2021 | $25.40M(+210.8%) | $6.77M(+1.5%) | $25.40M(+12.8%) |
| Sep 2021 | - | $6.67M(-1.8%) | $22.52M(+25.1%) |
| Jun 2021 | - | $6.79M(+31.7%) | $17.99M(+41.4%) |
| Mar 2021 | - | $5.16M(+32.6%) | $12.73M(+55.7%) |
| Dec 2020 | $8.17M(+619.4%) | $3.89M(+80.9%) | $8.17M(+75.0%) |
| Sep 2020 | - | $2.15M(+40.9%) | $4.67M(+69.6%) |
| Jun 2020 | - | $1.53M(+151.8%) | $2.75M(+124.4%) |
| Mar 2020 | - | $606.00K(+56.6%) | $1.23M(+97.6%) |
| Dec 2019 | $1.14M(+153.0%) | $387.00K(+65.4%) | $621.00K(+165.4%) |
| Sep 2019 | - | $234.00K | $234.00K |
| Dec 2018 | $449.00K | - | - |
FAQ
- What is Tarsus Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals annual SGA year-on-year change?
- What is Tarsus Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals quarterly SGA year-on-year change?
- What is Tarsus Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals TTM SGA year-on-year change?
What is Tarsus Pharmaceuticals annual SGA?
The current annual SGA of TARS is $237.31M
What is the all time high annual SGA for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high annual SGA is $237.31M
What is Tarsus Pharmaceuticals annual SGA year-on-year change?
Over the past year, TARS annual SGA has changed by +$128.61M (+118.32%)
What is Tarsus Pharmaceuticals quarterly SGA?
The current quarterly SGA of TARS is $85.00M
What is the all time high quarterly SGA for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high quarterly SGA is $85.00M
What is Tarsus Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, TARS quarterly SGA has changed by +$33.42M (+64.79%)
What is Tarsus Pharmaceuticals TTM SGA?
The current TTM SGA of TARS is -$1.40B
What is the all time high TTM SGA for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high TTM SGA is -$6.03M
What is Tarsus Pharmaceuticals TTM SGA year-on-year change?
Over the past year, TARS TTM SGA has changed by -$1.54B (-1061.77%)